Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 14;7(21):6428-6429.
doi: 10.1182/bloodadvances.2023011393.

Commentary on the 2023 ASH guidelines for thrombophilia testing in venous thromboembolism

Manu Juneja  1 , Jeff Szer  1   2
Affiliations
Comment

Commentary on the 2023 ASH guidelines for thrombophilia testing in venous thromboembolism

Manu Juneja et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: J.S. has received honoraria, travel funds and/or is a member of speakers’ bureau for Alexion AstraZeneca Rare Diseases, Sobi, Novartis, Samsung Bioepis, and Eli Lilly. M.J. declares no competing financial interests.

Comment on

References

    1. Middledorp S, Nieuwlaat R, Kreusiger LB, et al. American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: thrombophilia testing. Blood Adv. 2023 Published online 17 May. - PubMed
    1. Jalbert JJ, Chaudhari U, Zhang H, Weyne J, Shammo JM. Epidemiology of PNH and real-world treatment patterns following an incident PNH diagnosis in the US. Blood. 2019;134(Supplement_1):3407.
    1. Hill A, Kelly RJ, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121(25):4985–4996. quiz 5105. - PubMed
    1. Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: a British Society for Haematology guideline. Br J Haematol. 2022;198(3):443–458. - PMC - PubMed
    1. Woller SC, Stevens SM, Kaplan D, et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv. 2022;6(6):1661–1670. - PMC - PubMed